Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax + Chemotherapy in Children and Young Adults with Relapsed AML
NCT05183035Phase 3Recruiting
- Sponsor
- PedAL BCU
- Start
- Oct 2022
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 3 trial of venetoclax in acute myeloid leukemia (AML), sponsored by PedAL BCU. Started Oct 2022; status: recruiting.
02
Drugs
venetoclax
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT05183035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05183035.